Study of Combination of Cetuximab and Radiotherapy Added to the Standard Treatment for Oesophageal Adenocarcinoma (TRACC)

This study has been terminated.
(Experimental treatment not feasible due to high rate of drop out)
Sponsor:
Collaborator:
Merck KGaA
Information provided by:
UMC Utrecht
ClinicalTrials.gov Identifier:
NCT00827671
First received: January 22, 2009
Last updated: October 25, 2010
Last verified: October 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: August 2010
  Primary Completion Date: August 2010 (Final data collection date for primary outcome measure)